Where Will Pfizer Be in 5 Years?
Most investors who have been following Pfizer (NYSE: PFE) for awhile can't be overly pleased with how it has fared over the last five years. The big drugmaker badly underperformed the S&P 500 during the period. Its trailing-12-month revenues are lower today than they were at the end of 2015. And even after adjusting for divestitures, it hasn't delivered tremendous sales growth.
However, Pfizer today is in a far different position than it was even in its recent past. There are definitely reasons to be more optimistic about the company's future. Where will Pfizer be in five years? Here's my best-guess scenario.
Image source: Getty Images.
Source Fool.com
